POXEL: Major milestone as Twymeeg is approved in Japan | CORPORATE | EUR14.8 VS. 14(+97%)
POXEL - CORPORATE | EUR14.8 VS. 14(+97%)Major milestone as Twymeeg is approved in Japan
Imeglimine, now called Twymeeg, approved in Japan
From Japan to all Asia ?
A total of up to USD230m of milestones and royalties still to receive
Minor adjustment to our TP
Since 1996, Bryan, Garnier & Co has been growing with an absolute conviction that the investment banking landscape would experience a major revolution: most of the large local generalist banking groups will disappear to the benefit of a handful of global powerhouses, and an emerging group of independent, highly specialised boutique investment banks.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.